Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine in Laparoscopic Cholecystectomy
NCT04946396Completed
- Sponsor
- National Institute of Cardiology
- Start
- Apr 2022
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in cholecystectomy (2 arms), sponsored by National Institute of Cardiology. Primary endpoint: Change in microvascular flow index. Started Apr 2022; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
cholecystectomy
Beyond the preview
Go deeper on NCT04946396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04946396.